Literature DB >> 15320910

Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.

D Eastwood1, K C Gilmour, K Nistala, C Meaney, H Chapel, Z Sherrell, A D Webster, E G Davies, A Jones, H B Gaspar.   

Abstract

The molecular basis of common variable immunodeficiency (CVID) is undefined, and diagnosis requires exclusion of other diseases including X-linked lymphoproliferative disease (XLP). This rare disorder of immunedysregulation presents typically after Epstein-Barr virus infection and results from defects in the SAP (SLAM associated protein) gene. SAP mutations have been found in a few patients diagnosed previously as CVID, suggesting that XLP may mimic CVID, but no large-scale analysis of CVID patients has been undertaken. We therefore analysed 60 male CVID and hypogammaglobulinaemic patients for abnormalities in SAP protein expression and for mutations in the SAP gene. In this study only one individual, who was found later to have an X-linked family history, was found to have a genomic mutation leading to abnormal SAP cDNA and protein expression. These results demonstrate that SAP defects are rarely observed in CVID patients. We suggest that routine screening of SAP may only be necessary in patients with other suggestive clinical features.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320910      PMCID: PMC1809139          DOI: 10.1111/j.1365-2249.2004.02581.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Authors:  J Sumegi; D Huang; A Lanyi; J D Davis; T A Seemayer; A Maeda; G Klein; M Seri; H Wakiguchi; D T Purtilo; T G Gross
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

2.  An essential role for BLNK in human B cell development.

Authors:  Y Minegishi; J Rohrer; E Coustan-Smith; H M Lederman; R Pappu; D Campana; A C Chan; M E Conley
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

3.  Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.

Authors:  K C Gilmour; T Cranston; A Jones; E G Davies; D Goldblatt; A Thrasher; C Kinnon; K E Nichols; H B Gaspar
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

4.  Mutations in Igalpha (CD79a) result in a complete block in B-cell development.

Authors:  Y Minegishi; E Coustan-Smith; L Rapalus; F Ersoy; D Campana; M E Conley
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

Review 6.  X-linked lymphoproliferative disease: twenty-five years after the discovery.

Authors:  T A Seemayer; T G Gross; R M Egeler; S J Pirruccello; J R Davis; C M Kelly; M Okano; A Lanyi; J Sumegi
Journal:  Pediatr Res       Date:  1995-10       Impact factor: 3.756

7.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.

Authors:  K E Nichols; D P Harkin; S Levitz; M Krainer; K A Kolquist; C Genovese; A Bernard; M Ferguson; L Zuo; E Snyder; A J Buckler; C Wise; J Ashley; M Lovett; M B Valentine; A T Look; W Gerald; D E Housman; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

9.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

10.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.

Authors:  C Bottino; M Falco; S Parolini; E Marcenaro; R Augugliaro; S Sivori; E Landi; R Biassoni; L D Notarangelo; L Moretta; A Moretta
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  12 in total

1.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

Review 2.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  TACI mutation in common variable immunodeficiency and IgA deficiency.

Authors:  Rima Rachid; Emanuela Castigli; Raif S Geha; Francisco A Bonilla
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

4.  Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method.

Authors:  B L Ferry; J Jones; E A Bateman; N Woodham; K Warnatz; M Schlesier; S A Misbah; H H Peter; H M Chapel
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 5.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 6.  X-linked lymphoproliferative syndromes: brothers or distant cousins?

Authors:  Alexandra H Filipovich; Kejian Zhang; Andrew L Snow; Rebecca A Marsh
Journal:  Blood       Date:  2010-07-26       Impact factor: 22.113

Review 7.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

8.  TACI, isotype switching, CVID and IgAD.

Authors:  Emanuela Castigli; Raif S Geha
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 9.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

Review 10.  Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

Authors:  C Bacchelli; S Buckridge; A J Thrasher; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2007-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.